BioSpace News Archive

TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that management will present at the LD Micro Invitational XI investor conference taking place virtually June 8-10, 2021.

Amgen (NASDAQ:AMGN) will present at the 2021 Jefferies Healthcare Conference at 1:30 p.m. ET on Thursday, June 3, 2021. Murdo Gordon, executive vice president of Global Commercial Operations at Amgen will present at the conference

The global nephrostomy devices market has witnessed a steady growth over the years, owing to the convenience it provides to the patients suffering from hydronephrosis.

Ongoing advancements in assistive reproductive technology and artificial insemination fuel the sperm processing media market

According to Transparency Market Research (TMR), the global mortuary equipment market has fragmented landscape as numerous local and global companies are offering services in the country.

Transparency Market Research has published a new report titled, “Global Neurotrophic Keratitis Market”.

Ibere Pharmaceuticals (NYSE: IBER) (the “Company”) today announced that it received a notice on May 25, 2021 from the New York Stock Exchange (the “NYSE”) indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Quarterly Report

Increasing cases of cardiac arrest and growing investment in research and development for advanced hypothermia management systems will improve sales prospects

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has closed a minority investment in Miromatrix, a biotechnology company working to eliminate the need for an organ transplant waiting list through the development of implantable engineered biological organs